Vivos Therapeutics, Inc. Operating Lease, Payments
Vivos Therapeutics, Inc. (VVOS) reported Operating Lease, Payments of $1.11 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-04-15
- Vivos Therapeutics, Inc. operating lease, payments for the quarter ending 2024-06-30 was $156.00K.
- Vivos Therapeutics, Inc. operating lease, payments for the quarter ending 2024-03-31 was $153.00K.
- Vivos Therapeutics, Inc. operating lease, payments for fiscal 2025 was $1.11M, a 80.91% increase from fiscal 2024.
- Vivos Therapeutics, Inc. operating lease, payments for fiscal 2024 was $613.00K, a 1.83% increase from fiscal 2023.
- Vivos Therapeutics, Inc. operating lease, payments for fiscal 2023 was $602.00K, a 37.44% increase from fiscal 2022.
- Vivos Therapeutics, Inc. operating lease, payments for fiscal 2022 was $438.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 12 month |
|---|---|---|---|
| 2025-12-31 | $1.11M 10-K · filed 2026-04-15 | ||
| 2024-12-31 | $613.00K 10-K · filed 2026-04-15 | ||
| 2024-06-30 | $156.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $309.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $153.00K 10-Q · filed 2024-05-14 | ||
| 2023-12-31 | $602.00K 10-K · filed 2025-03-31 | ||
| 2022-12-31 | $438.00K 10-K/A · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |